News

Recor Medical's Breakthrough Treatment for Resistant Hypertension

Recor Medical's Breakthrough Treatment for Resistant Hypertension

Recor Medical Achieves Milestone with Innovative Treatment

Recor Medical, Inc., a proud subsidiary of Otsuka Medical Devices Co., Ltd., has exciting news for the medical community and patients alike. The company announced that its advanced Paradise™ Ultrasound Renal Denervation (uRDN) system has received the green light for manufacturing and marketing in Japan, offering a fresh therapeutic avenue for those battling resistant hypertension.

Significance of the Approval

This groundbreaking approval represents a historic first for the Japanese market, as it is the initial medical device authorized for treating resistant hypertension. This is paramount, as resistant hypertension presents significant health risks and challenges, often leading to cardiovascular complications and mortality. The approval was influenced by the encouraging outcomes from the RADIANCE-HTN TRIO study, a clinical trial that showcased the effectiveness of the Paradise system across diverse populations in the U.S. and Europe.

Clinical Study Insights

The RADIANCE-HTN TRIO study was meticulously designed as a randomized, sham-controlled trial, focusing on patients with resistant hypertension who were on a strict regimen of triple antihypertensive therapy, including diuretics. The results were remarkable, demonstrating a substantial reduction in daytime ambulatory systolic blood pressure (ASBP) just two months following treatment, predicting a new standard in hypertension management. Furthermore, participants experienced a consistent safety profile throughout the trial, highlighting the system's promise.

Innovative Technology of Paradise uRDN System

What sets the Paradise system apart is its state-of-the-art ultrasound technology, which effectively targets the sympathetic nerves encircling the renal arteries. By administering two to three doses of 360-degree ultrasound energy for seven seconds each, the system effectively inhibits the overactive nerve activity that contributes to high blood pressure. Additionally, it incorporates an innovative HydroCooling™ feature that circulates sterile water, safeguarding the renal arterial wall during the procedure, ensuring patient safety and comfort.

Expert Opinions

Leading experts have expressed optimism about the potential impact of this treatment. Kazuomi Kario, President of the Japanese Society of Hypertension, voiced his enthusiasm, noting, "Resistant hypertension poses unique challenges in patient care. The Paradise uRDN system will undoubtedly provide a new therapeutic option for patients struggling with this condition."

Yoshio Kobayashi of the Japanese Circulation Society emphasized the necessity of addressing cardiovascular diseases, citing that hypertension remains a leading factor. He stated, "With the introduction of the Paradise uRDN system, we can broaden our treatment horizons, aiding in the prevention of serious cardiovascular events."

Path Ahead for Recor Medical

With this key milestone, Recor Medical aims to expand access to this cutting-edge treatment beyond Japan, aligning with its global mission of improving patient lives. Lara Barghout, President and CEO of Recor Medical, proudly shared, "This approval not only marks a significant accomplishment for our team but also empowers patients who previously had limited options for managing their hypertension."

The success of the Paradise uRDN system in the U.S., where it received FDA approval, has already been monumental, and the company is poised to extend its impact further. The system has also been introduced in the European Union, underpinned by the Global Paradise System (GPS) post-market registry launched to gather long-term data and insights. Furthermore, compliance with local regulations in Japan requires a post-marketing surveillance (PMS) study, reinforcing Recor's commitment to thorough research and patient-wellbeing.

Conclusion

Recor Medical is on the forefront of medical technology innovation, with the Paradise system serving as a testament to the company's dedication to revolutionizing the treatment landscape for resistant hypertension. As they continue to work closely with healthcare professionals and institutions, the focus remains on providing transformative solutions that enhance patient outcomes and quality of life across the globe.

Frequently Asked Questions

What is the Paradise uRDN system?

The Paradise uRDN system is an innovative ultrasound-based treatment designed to reduce blood pressure by targeting active sympathetic nerves around the renal arteries.

Why is this approval significant for Japan?

This is Japan's first approved medical device for treating resistant hypertension, enhancing treatment options for patients who do not respond well to conventional medications.

What were the outcomes of the RADIANCE-HTN TRIO study?

The study demonstrated significant reductions in daytime ambulatory systolic blood pressure among participants, confirming the efficacy and safety of the Paradise system.

How does the HydroCooling™ system work?

The HydroCooling™ system circulates sterile water through the treatment balloon to protect the renal arteries during the procedure, enhancing safety for patients.

What is Recor Medical's mission moving forward?

Recor Medical aims to enhance global access to innovative hypertension treatments, ensuring that patients worldwide benefit from advanced medical solutions that improve their lives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MERSCO’s Holiday Push Tests Backyard Play Demand in 2026

Updated Category News Views 61

A trampoline sale is not exactly a macroeconomic bellwether, but it does expose a useful little corner of holiday spending: parents buying big, awkward, discretionary stuff that has to earn its space in the yard. MERSCO is joining Amazon’s Black Friday and Cyber Monday window from November 19 through November 30, 2026, with discounts reaching 38% on selected products....

Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum

Updated Category News Views 106

Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...

Continue Reading
America's Group Adds Swansea to Its UK Auction Map

Updated Category News Views 117

A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...

Continue Reading
Volta M100 Puts Flexibility at Pad Printing's Center

Updated Category News Views 61

A tabletop printer rarely earns a second glance, but the Volta M100 is making a sensible argument: small manufacturers do not need another rigid box that becomes obsolete the minute a job changes. Boston Industrial Solutions has introduced the Volta M100 as a pad-printing machine built around adjustability, operator convenience, and software that can be upgraded as...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 104

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 182

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading
RazorMetrics' Fast 500 Run Merits a Harder Investor Look

Updated Category News Views 66

A 4,488% growth figure can make even a seasoned skeptic sit upright. RazorMetrics landed at No. 20 on Deloitte's 2026 Technology Fast 500 after ranking No. 12 in 2025, and it again took the top Texas slot. That is serious momentum for an Austin company working on one of healthcare's most stubborn expenses: prescription drugs. Still, this is healthcare cost containment,...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 173

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 125

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Three Deal Reviews Put Merger Terms Under Scrutiny

Updated Category News Views 140

Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth...

Continue Reading

Top 5 Most Recently Viewed Articles

Ford Motor Company Faces Legal Challenges: Key Insights

Updated Category News Views 119

Understanding the Legal Landscape for Ford Motor Company As investors navigate the intricate world of stock ownership, recent events surrounding Ford Motor Company have raised eyebrows. The company currently finds itself at the center of a class action lawsuit involving shareholders who acquired stock during a specific period. Class Action Overview and Important Dates...

Continue Reading
Transforming the Specialty Fats and Oils Industry for Success

Updated Category News Views 188

A Deep Dive into the Specialty Fats and Oils Market The landscape of the specialty fats and oils market is rapidly transforming, growing from its valuation of US$ 16.12 billion in the preceding year to a staggering US$ 31.69 billion by 2033, marking a robust CAGR of 7.8% during the next financial stretch. This growth signals a significant shift in industry dynamics and...

Continue Reading
C3.ai: Analyzing Current Trends in the Options Market

Updated Category News Views 241

Current Sentiment on C3.ai Recently, well-known investors—often referred to as whales—have taken a decidedly negative stance towards C3.ai. This growing skepticism stems from the history of options involving the company's stock. An analysis of C3.ai's (AI) trading patterns uncovered nine notable trades. Digging deeper into these transactions shows that only 22% of...

Continue Reading
CytomX Therapeutics Completes $100 Million Stock Offering

Updated Category News Views 315

CytomX Therapeutics Completes $100 Million Stock Offering CytomX Therapeutics, Inc. (NASDAQ: CTMX), based in South San Francisco, has just announced the pricing of an extensive stock offering. The company is set to offer 76,923,076 shares of its common stock at a price of $1.30 per share. This significant transaction aims to raise approximately $100 million and is being...

Continue Reading
Wall Street's Bullish Coverage Initiation Highlights for NKE and Others

Updated Category News Views 120

Wall Street Analysts Initiate Coverage on Key Stocks In a dynamic market landscape, top analysts have recently adjusted their ratings on several prominent companies. Their insights provide a glimpse into potential future performance for investors. Today, we spotlight these analyst ratings and what they mean for some notable stocks. NIKE, Inc. (NKE) Coverage by Needham...

Continue Reading